{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:10:37Z","timestamp":1789607437040,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Marfan syndrome (MFS) is a genetic disorder caused by an <jats:italic>FBN1<\/jats:italic> variant and is diagnosed based on the revised Ghent criteria, which incorporate clinical manifestations and genetic testing. Up-to-date <jats:italic>FBN1<\/jats:italic> variant interpretation is crucial for proper diagnosis and management of MFS; however, some <jats:italic>FBN1<\/jats:italic> variants of uncertain significance (VUSs) remain inconclusive despite applying Clinical Genome Resource (ClinGen) <jats:italic>FBN1<\/jats:italic>-specific guideline. Recently, the ClinGen guidance for PP1\/BS4 co-segregation and PP4 phenotype specificity criteria (new PP1\/PP4 criteria) were released. Here, we performed reassessment of <jats:italic>FBN1<\/jats:italic> VUSs using these new PP1\/PP4 criteria. <jats:italic>FBN1<\/jats:italic> VUSs collected from December 2015 to April 2024 were reassessed according to the ClinGen <jats:italic>FBN1<\/jats:italic>-specific guideline and new PP1\/PP4 criteria. Medical records and previous studies were reviewed to evaluate the phenotype-specificity of evidence based on the revised Ghent criteria. Collectively, 927 patients with suspected MFS underwent <jats:italic>FBN1<\/jats:italic> sequencing and 72 VUSs were detected. When applying the <jats:italic>FBN1<\/jats:italic>-specific guideline only, of 72 VUSs, 29 (40.3%) were reclassified as pathogenic variants (PVs) or likely PVs (LPVs). When additionally applying the new PP1\/PP4 criteria, 16 (37.2%) of the remaining 43 VUSs were reclassified as LPVs. After reassessing <jats:italic>FBN1<\/jats:italic> VUSs according to the new PP1\/PP4 criteria, the rate of reclassification from VUS to PV\/LPV significantly increased from 40.3% to 62.5%. The new PP1\/PP4 criteria provide sufficient evidence for evaluating the pathogenicity of <jats:italic>FBN1<\/jats:italic> variants detected in MFS patients fulfilling the revised Ghent criteria and will be helpful in clinical analysis.<\/jats:p>","DOI":"10.1038\/s41431-025-01826-9","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T16:21:41Z","timestamp":1743524501000},"page":"666-674","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Reassessment of FBN1 variants of uncertain significance using updated ClinGen guidance for PP1\/BS4 and PP4 criteria"],"prefix":"10.1038","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6270-9205","authenticated-orcid":false,"given":"Ju Hyeon","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-gon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4319-7029","authenticated-orcid":false,"given":"Shin Yi","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duk-Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ja-Hyun","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1440-3583","authenticated-orcid":false,"given":"Taek Kyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6558-5236","authenticated-orcid":false,"given":"Mi-Ae","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"key":"1826_CR1","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.21037\/cdt.2017.09.14","volume":"8","author":"EJ Zucker","year":"2018","unstructured":"Zucker EJ. Syndromes with aortic involvement: pictorial review. Cardiovasc Diagn Ther. 2018;8:S71\u201381.","journal-title":"Cardiovasc Diagn Ther"},{"key":"1826_CR2","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/jmg.2009.072785","volume":"47","author":"BL Loeys","year":"2010","unstructured":"Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010;47:476\u201385.","journal-title":"J Med Genet"},{"key":"1826_CR3","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1002\/humu.21525","volume":"32","author":"M Baetens","year":"2011","unstructured":"Baetens M, Van Laer L, De Leeneer K, Hellemans J, De Schrijver J, Van De Voorde H, et al. Applying massive parallel sequencing to molecular diagnosis of Marfan and Loeys-Dietz syndromes. Hum Mutat. 2011;32:1053\u201362.","journal-title":"Hum Mutat"},{"key":"1826_CR4","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.gim.2021.12.015","volume":"24","author":"JAN Meester","year":"2022","unstructured":"Meester JAN, Peeters S, Van Den Heuvel L, Vandeweyer G, Fransen E, Cappella E, et al. Molecular characterization and investigation of the role of genetic variation in phenotypic variability and response to treatment in a large pediatric Marfan syndrome cohort. Genet Med. 2022;24:1045\u201353.","journal-title":"Genet Med"},{"key":"1826_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R","volume":"62","author":"A De Paepe","year":"1996","unstructured":"De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyeritz RE. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet. 1996;62:417\u201326.","journal-title":"Am J Med Genet"},{"key":"1826_CR6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"1826_CR7","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1002\/humu.23645","volume":"39","author":"EA Rivera-Mu\u00f1oz","year":"2018","unstructured":"Rivera-Mu\u00f1oz EA, Milko LV, Harrison SM, Azzariti DR, Kurtz CL, Lee K, et al. ClinGen Variant Curation Expert Panel experiences and standardized processes for disease and gene-level specification of the ACMG\/AMP guidelines for sequence variant interpretation. Hum Mutat. 2018;39:1614\u201322.","journal-title":"Hum Mutat"},{"key":"1826_CR8","unstructured":"FBN1 variant curation expert panel. Clingen FBN1 expert panel specifications to the ACMG\/AMP variant interpretation guidelines version 1. 2022. Available: https:\/\/clinicalgenome.org\/site\/assets\/files\/7445\/clingen_fbn1_acmg_specifications_v1.pdf. Accessed 17 May 2024."},{"key":"1826_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1136\/jmg-2023-109433","volume":"61","author":"E Yoon","year":"2023","unstructured":"Yoon E, Lee JK, Park TK, Chang SA, Huh J, Kim JW, et al. Experience of reassessing FBN1 variants of uncertain significance by gene-specific guidelines. J Med Genet. 2023;61:57\u201360.","journal-title":"J Med Genet"},{"key":"1826_CR10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3343\/alm.2023.0152","volume":"44","author":"SW Kim","year":"2024","unstructured":"Kim SW, Kim B, Kim Y, Lee KA. Re-evaluation of a Fibrillin-1 Gene Variant of Uncertain Significance Using the ClinGen Guidelines. Ann Lab Med. 2024;44:271\u201378.","journal-title":"Ann Lab Med"},{"key":"1826_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ajhg.2023.11.009","volume":"111","author":"LG Biesecker","year":"2024","unstructured":"Biesecker LG, Byrne AB, Harrison SM, Pesaran T, Sch\u00e4ffer AA, Shirts BH, et al. ClinGen guidance for use of the PP1\/BS4 co-segregation and PP4 phenotype specificity criteria for sequence variant pathogenicity classification. Am J Hum Genet. 2024;111:24\u201338.","journal-title":"Am J Hum Genet"},{"key":"1826_CR12","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1002\/humu.24088","volume":"41","author":"SV Tavtigian","year":"2020","unstructured":"Tavtigian SV, Harrison SM, Boucher KM, Biesecker LG. Fitting a naturally scaled point system to the ACMG\/AMP variant classification guidelines. Hum Mutat. 2020;41:1734\u20137.","journal-title":"Hum Mutat"},{"key":"1826_CR13","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s10038-022-01044-x","volume":"67","author":"JA Kim","year":"2022","unstructured":"Kim JA, Kwon WK, Kim JW, Jang JH. Variation spectrum of MECP2 in Korean patients with Rett and Rett-like syndrome: a literature review and reevaluation of variants based on the ClinGen guideline. J Hum Genet. 2022;67:601\u20136.","journal-title":"J Hum Genet"},{"key":"1826_CR14","doi-asserted-by":"crossref","unstructured":"Bennett G, Karbassi I, Chen W, Harrison SM, Lebo MS, Meng L, et al. Distinct rates of VUS reclassification are observed when subclassifying VUS by evidence level. Genet Med. 2025;28:101400.","DOI":"10.1016\/j.gim.2025.101400"},{"key":"1826_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1399-0004.2008.01007.x","volume":"74","author":"M Attanasio","year":"2008","unstructured":"Attanasio M, Lapini I, Evangelisti L, Lucarini L, Giusti B, Porciani M, et al. FBN1 mutation screening of patients with Marfan syndrome and related disorders: detection of 46 novel FBN1 mutations. Clin Genet. 2008;74:39\u201346.","journal-title":"Clin Genet"},{"key":"1826_CR16","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ymgme.2014.03.011","volume":"112","author":"JP Lerner-Ellis","year":"2014","unstructured":"Lerner-Ellis JP, Aldubayan SH, Hernandez AL, Kelly MA, Stuenkel AJ, Walsh J, et al. The spectrum of FBN1, TGF\u03b2R1, TGF\u03b2R2 and ACTA2 variants in 594 individuals with suspected Marfan Syndrome, Loeys-Dietz Syndrome or Thoracic Aortic Aneurysms and Dissections (TAAD). Mol Genet Metab. 2014;112:171\u20136.","journal-title":"Mol Genet Metab"},{"key":"1826_CR17","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.3390\/genes13112108","volume":"13","author":"KH Kim","year":"2022","unstructured":"Kim KH, Kim TY, Kim SJ, Cho YG, Park J, Jang W. Targeted Panel Sequencing Identifies an Intronic c.5225-3C>G Variant of the FBN1 Gene Causing Sporadic Marfan Syndrome with Annuloaortic Ectasia. Genes. 2022;13:2108.","journal-title":"Genes."},{"key":"1826_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/gim.2014.91","volume":"17","author":"LM Baudhuin","year":"2015","unstructured":"Baudhuin LM, Kotzer KE, Lagerstedt SA. Increased frequency of FBN1 truncating and splicing variants in Marfan syndrome patients with aortic events. Genet Med. 2015;17:177\u201387.","journal-title":"Genet Med"},{"key":"1826_CR19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.117.002039","volume":"11","author":"L Mui\u00f1o-Mosquera","year":"2018","unstructured":"Mui\u00f1o-Mosquera L, Steijns F, Audenaert T, Meerschaut I, De Paepe A, Steyaert W, et al. Tailoring the American College of Medical Genetics and Genomics and the Association for Molecular Pathology Guidelines for the Interpretation of Sequenced Variants in the FBN1 Gene for Marfan Syndrome: Proposal for a Disease- and Gene-Specific Guideline. Circ Genom Precis Med. 2018;11:e002039.","journal-title":"Circ Genom Precis Med"},{"key":"1826_CR20","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.jfma.2021.08.016","volume":"121","author":"DM Duan","year":"2022","unstructured":"Duan DM, Chiu HH, Chen PL, Yeh PT, Yu CW, Yang KC, et al. Clinical manifestations and genetic characteristics in the Taiwan thoracic aortic aneurysm and dissection cohort - a prospective cohort study. J Formos Med Assoc. 2022;121:1093\u2013101.","journal-title":"J Formos Med Assoc"},{"key":"1826_CR21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ejmg.2010.06.002","volume":"53","author":"L Evangelisti","year":"2010","unstructured":"Evangelisti L, Lucarini L, Attanasio M, Lapini I, Giusti B, Porciani C, et al. A single heterozygous nucleotide substitution displays two different altered mechanisms in the FBN1 gene of five Italian Marfan patients. Eur J Med Genet. 2010;53:299\u2013302.","journal-title":"Eur J Med Genet"},{"key":"1826_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2021.108570","volume":"207","author":"D Guo","year":"2021","unstructured":"Guo D, Jin G, Zhou Y, Zhang X, Cao Q, Lian Z, et al. Mutation spectrum and genotype-phenotype correlations in Chinese congenital ectopia lentis patients. Exp Eye Res. 2021;207:108570.","journal-title":"Exp Eye Res"},{"key":"1826_CR23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1167\/iovs.65.1.20","volume":"65","author":"D Guo","year":"2024","unstructured":"Guo D, Li S, Xiao X, Jiang Y, Wang Y, Jin G, et al. Clinical and Genetic Landscape of Ectopia Lentis Based on a Cohort of Patients From 156 Families. Invest Ophthalmol Vis Sci. 2024;65:20.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1826_CR24","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3390\/diagnostics11061057","volume":"11","author":"JS Cho","year":"2021","unstructured":"Cho JS, Park J, Kwon JB, Kim DW, Park MW. 3D Printed Personalized External Aortic Root Model in Marfan Syndrome with Isolated Sinus of Valsalva Aneurysm Caused by a Novel Pathogenic FBN1 p.Gly1127Cys Variant. Diagnostics. 2021;11:1057.","journal-title":"Diagnostics"},{"key":"1826_CR25","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/humu.9505","volume":"28","author":"P Comeglio","year":"2007","unstructured":"Comeglio P, Johnson P, Arno G, Brice G, Evans A, Aragon-Martin J, et al. The importance of mutation detection in Marfan syndrome and Marfan-related disorders: report of 193 FBN1 mutations. Hum Mutat. 2007;28:928.","journal-title":"Hum Mutat"},{"key":"1826_CR26","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.cca.2019.10.037","volume":"501","author":"L Mannucci","year":"2020","unstructured":"Mannucci L, Luciano S, Salehi LB, Gigante L, Conte C, Longo G, et al. Mutation analysis of the FBN1 gene in a cohort of patients with Marfan Syndrome: A 10-year single center experience. Clin Chim Acta. 2020;501:154\u201364.","journal-title":"Clin Chim Acta"},{"key":"1826_CR27","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1089\/gte.2006.258-264","volume":"10","author":"L Tjeldhorn","year":"2006","unstructured":"Tjeldhorn L, Rand-Hendriksen S, Gervin K, Brandal K, Inderhaug E, Geiran O, et al. Rapid and efficient FBN1 mutation detection using automated sample preparation and direct sequencing as the primary strategy. Genet Test. 2006;10:258\u201364.","journal-title":"Genet Test"},{"key":"1826_CR28","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41431-024-01554-6","volume":"32","author":"L Basel-Salmon","year":"2024","unstructured":"Basel-Salmon L. Phenotypic compatibility and specificity in genomic variant classification. Eur J Hum Genet. 2024;32:471\u20133.","journal-title":"Eur J Hum Genet"},{"key":"1826_CR29","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1399-0004.2011.01646.x","volume":"80","author":"T Radonic","year":"2011","unstructured":"Radonic T, de Witte P, Groenink M, de Bruin-Bon RA, Timmermans J, Scholte AJ, et al. Critical appraisal of the revised Ghent criteria for diagnosis of Marfan syndrome. Clin Genet. 2011;80:346\u201353.","journal-title":"Clin Genet"},{"key":"1826_CR30","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/ajmg.a.34392","volume":"158A","author":"JH Yang","year":"2012","unstructured":"Yang JH, Han H, Jang SY, Moon JR, Sung K, Chung TY, et al. A comparison of the Ghent and revised Ghent nosologies for the diagnosis of Marfan syndrome in an adult Korean population. Am J Med Genet A. 2012;158A:989\u201395.","journal-title":"Am J Med Genet A"},{"key":"1826_CR31","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/ajmg.a.61441","volume":"182","author":"TT Vanem","year":"2020","unstructured":"Vanem TT, B\u00f6ker T, Sandvik GF, Kirkhus E, Smith HJ, Andersen K, et al. Marfan syndrome: Evolving organ manifestations-A 10-year follow-up study. Am J Med Genet A. 2020;182:397\u2013408.","journal-title":"Am J Med Genet A"},{"key":"1826_CR32","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1399-0004.2011.01703.x","volume":"81","author":"L Faivre","year":"2012","unstructured":"Faivre L, Collod-Beroud G, Ad\u00e8s L, Arbustini E, Child A, Callewaert BL, et al. The new Ghent criteria for Marfan syndrome: what do they change? Clin Genet. 2012;81:433\u201342.","journal-title":"Clin Genet"},{"key":"1826_CR33","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1161\/CIRCULATIONAHA.109.887042","volume":"120","author":"D Attias","year":"2009","unstructured":"Attias D, Stheneur C, Roy C, Collod-B\u00e9roud G, Detaint D, Faivre L, et al. Comparison of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations in Marfan syndrome and related disorders. Circulation. 2009;120:2541\u20139.","journal-title":"Circulation"},{"key":"1826_CR34","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jgg.2019.04.003","volume":"46","author":"M Qin","year":"2019","unstructured":"Qin M, Zhu X, Zhang Z, Li X, Yan Z, Wang Y, et al. Genetic analysis and preimplantation genetic diagnosis of Chinese Marfan syndrome patients. J Genet Genomics. 2019;46:319\u201323.","journal-title":"J Genet Genomics"},{"key":"1826_CR35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijcard.2022.11.023","volume":"373","author":"S Thunstr\u00f6m","year":"2023","unstructured":"Thunstr\u00f6m S, Thunstr\u00f6m E, Naess\u00e9n S, Berntorp K, Laczna Kitlinski M, Ekman B, et al. Aortic size predicts aortic dissection in Turner syndrome - A 25-year prospective cohort study. Int J Cardiol. 2023;373:47\u201354.","journal-title":"Int J Cardiol"},{"key":"1826_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.25009","volume":"38","author":"JA Kim","year":"2024","unstructured":"Kim JA, Jang MA, Jang SY, Kim DK, Kim YG, Kim JW, et al. Overcoming challenges associated with identifying FBN1 deep intronic variants through whole-genome sequencing. J Clin Lab Anal. 2024;38:e25009.","journal-title":"J Clin Lab Anal"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01826-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01826-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01826-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T13:29:15Z","timestamp":1760707755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01826-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["1826"],"URL":"https:\/\/doi.org\/10.1038\/s41431-025-01826-9","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"25 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the IRB of SMC, Seoul, Korea (approval no. 2024-02-006). The requirement of informed consent was waived due to its retrospective nature.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}